Industry Matchmaking Sessions
Wednesday, May 4 – Friday, May 6, 2016Marriott Wardman Park Hotel
Individually scheduled meetings
New this year, ASGCT’s Industry Matchmaking Sessions will provide an opportunity for abstract presenters at the 19th Annual Meeting to meet one-on-one with a senior industry representative and give a short 5-10-minute presentation of their work to discuss potential new collaborative research agreements, technologies, and products with industry representatives.
Participating companies include:
- Audentes Therapeutics
- Bayer
- BioMarin
- bluebird bio
- CRISPR Therapeutics
- GlaxoSmithKline
- Lentigen Technology Inc., A Miltenyi Biotec Company
- Merck
- Pfizer
- Precision BioSciences
- Precision Nanosystems
- Sangamo BioSciences
- Sanofi
- Spark Therapeutics
- Tocagen
If you are planning on submitting an abstract at next year’s 20th Annual Meeting, please consider signing up for this unique opportunity in 2017 during the abstract submission process!
The evolution of gene editing technologies [ZFN and CRISPR - Cas9] the elimination of HIV is possible in the future.
ReplyDelete